Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
US Stock MarketDetailed Quotes
GOVX GeoVax Labs
- 1.020
- -0.080-7.27%
Close Apr 4 16:00 ET
- 1.000
- -0.020-1.96%
Post 20:01 ET
14.12MMarket Cap-0.21P/E (TTM)
1.078High1.010Low312.73KVolume1.050Open1.100Pre Close324.74KTurnover2.27%Turnover RatioLossP/E (Static)13.84MShares11.18052wk High2.79P/B14.05MFloat Cap1.01052wk Low--Dividend TTM13.78MShs Float130.650Historical High--Div YieldTTM6.18%Amplitude1.010Historical Low1.038Avg Price1Lot Size
About GeoVax Labs Company
GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola, Sudan, Marburg, and Lassa fever, the Zika virus and malaria, and human immunodeficiency virus, as well as immunotherapies for solid tumor cancers. The company was founded in June 1988 and is headquartered in Smyrna, GA.
Company Profile
SymbolGOVX
Company NameGeoVax Labs
Listing DateSep 25, 2020
Founded1988
CEOMr. David A. Dodd
MarketNASDAQ
Employees17
Fiscal Year Ends12-31
Address1900 Lake Park Drive,Suite 380
CitySmyrna
ProvinceGeorgia
CountryUnited States of America
Zip Code30080
Phone1-678-384-7220
Websitehttp://www.geovax.com
Company Executives
- Name
- Position
- Salary
- David A. Dodd
- Chairman of the Board, Chief Executive Officer and President
- 384.20K
- Dr. Mark J. Newman, PhD
- Chief Scientific Officer
- 291.50K
- Dr. Kelly T. McKee, M.D.
- Chief Medical Officer
- 361.03K
- Mark W. Reynolds, C.P.A.
- Chief Financial Officer, Principal Accounting Officer and Corporate Secretary
- --
- Dr. John W. Sharkey, PhD
- Vice President, Business Development
- --
- Nicole Lemerond
- Independent Director
- 32.50K
- John N. Spencer, C.P.A.,Jr
- Independent Director
- 45.00K
- Dean G. Kollintzas
- Independent Director
- 37.50K
- Dr. Robert T. McNally,PhD
- Lead Independent Director
- 47.50K
- Dr. Randal D. Chase, PhD
- Independent Director
- 47.50K
- Dr. Jayne Morgan, M.D.
- Independent Director
- 30.00K
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call